hematologic malignancies
BostonGene, Mount Sinai Partner on Multiple Myeloma Precision Oncology Study
The study will use BostonGene's assays, including whole-exome and whole-transcriptome sequencing, to inform patients' clinical care and advance drug development.
City of Hope, Institute for Follicular Lymphoma Innovation Partner on $2M Research Program
The three-year effort will use DNA profiling, proteomics, and machine learning techniques to explore potential triggers of spontaneous remission.
The company is gearing up to launch a new rapid NGS test for acute myeloid leukemia and a liquid biopsy comprehensive genomic profiling assay.
Bionano Genomics Upbeat on Further Clinical Adoption of Optical Genome Mapping With New CPT Code
Premium
The Category I CPT code paves the way for reimbursement of OGM-based clinical tests, though details on pricing and insurance coverage are still unclear.
Clonal Hematopoiesis Drivers Detected in Selection-Focused Study
Researchers performed gene-level selection analyses on blood-based exome sequences from UK Biobank participants, narrowing in on 17 clonal hematopoiesis driver genes.